Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,900 | 3 | 84.4% |
| Food and Beverage | $648.88 | 8 | 9.3% |
| Travel and Lodging | $418.69 | 5 | 6.0% |
| Education | $22.96 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,876 | 3 | $0 (2020) |
| TESARO, Inc. | $2,807 | 9 | $0 (2017) |
| Puma Biotechnology, Inc. | $1,137 | 3 | $0 (2019) |
| Foundation Medicine, Inc. | $147.24 | 1 | $0 (2018) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $11.04 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $22.96 | 2 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $2,819 | 2 | AstraZeneca Pharmaceuticals LP ($2,819) |
| 2019 | $1,137 | 3 | Puma Biotechnology, Inc. ($1,137) |
| 2018 | $147.24 | 1 | Foundation Medicine, Inc. ($147.24) |
| 2017 | $2,865 | 10 | TESARO, Inc. ($2,807) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 03/17/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | In-kind items and services | $11.04 | General |
| Category: Oncology | ||||||
| 07/09/2020 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 01/09/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/20/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Travel and Lodging | Cash or cash equivalent | $12.06 | General |
| Category: Oncology | ||||||
| 04/18/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 04/18/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 06/12/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $147.24 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $239.20 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $116.63 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $68.40 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $59.58 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $56.91 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $44.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $6.80 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $115.38 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2017 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $57.72 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 9 | 312 | 486 | $124,302 | $54,622 |
| 2020 | 7 | 237 | 385 | $103,062 | $37,774 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 73 | 172 | $52,460 | $25,493 | 48.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 87 | 103 | $24,411 | $10,478 | 42.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 28 | 59 | $13,511 | $5,158 | 38.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 55 | $8,690 | $3,362 | 38.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $7,395 | $3,020 | 40.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 18 | 22 | $5,324 | $2,256 | 42.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 22 | 23 | $5,014 | $1,977 | 39.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 14 | $4,116 | $1,556 | 37.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 21 | $3,381 | $1,323 | 39.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 52 | 159 | $50,178 | $18,629 | 37.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 86 | 91 | $21,567 | $7,193 | 33.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 20 | 36 | $8,244 | $3,229 | 39.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 26 | 44 | $6,914 | $2,686 | 38.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 15 | 15 | $6,767 | $2,511 | 37.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 23 | 25 | $6,050 | $2,204 | 36.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 15 | 15 | $3,342 | $1,322 | 39.6% |
About Dr. Susan Rabinowe, MD
Dr. Susan Rabinowe, MD is a Hematology & Oncology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447253422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Rabinowe, MD has received a total of $6,991 in payments from pharmaceutical and medical device companies, with $22.96 received in 2021. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($5,900).
As a Medicare-enrolled provider, Rabinowe has provided services to 549 Medicare beneficiaries, totaling 871 services with total Medicare billing of $92,396. Data is available for 2 years (2020–2021), covering 16 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Hartford, CT
- Active Since 05/24/2005
- Last Updated 08/04/2010
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1447253422
Products in Payments
- ZEJULA (Drug) $2,807
- Nerlynx (Drug) $1,137
- FOUNDATIONONE (Device) $147.24
- LYNPARZA (Drug) $57.72
- FARXIGA (Drug) $18.65
- OPDIVO (Biological) $11.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Hartford
Madhavi Gorusu, M.d, M.D
Hematology & Oncology — Payments: $399,570
Mr. Todd Alekshun, M.d, M.D
Hematology & Oncology — Payments: $83,681
Paul Dekker, Md, MD
Hematology & Oncology — Payments: $10,781
Yelena Pristyazhnyuk
Hematology & Oncology — Payments: $8,961
Mohammad Pazooki, Md, MD
Hematology & Oncology — Payments: $7,495
Stephen Firshein, Md, MD
Hematology & Oncology — Payments: $7,343